Karalee Close
Managing Director & Senior Partner; Global Leader, Technology Advantage Practice
London
Managing Director & Senior Partner; Global Leader, Technology Advantage Practice
London
Karalee Close is the global leader of Boston Consulting Group's Technology Advantage practice and a core member of DigitalBCG’s Global Senior Management team. She is an active sponsor of the firm’s Women@BCG and Women in Technology initiatives.
Karalee’s client work focuses on digital and technology-enabled transformations in health care and other industry sectors, including consumer products, media and entertainment, oil and gas, retail, technology, and telecommunications. In the public sector, she focuses on digital strategy, data-driven transformation, operating model development, capability building, cost reduction, risk and portfolio management, and IT governance.
Prior to joining BCG, Karalee held senior management positions in Canadian hospitals.
To accelerate a digital and IT transformation and build value faster, focus on business outcomes and decouple the digital transformation from core system replacement.
As companies face increased uncertainty and market volatility, the ability to respond effectively to ambiguity and unpredictability will be a critical advantage.
Today’s agile, collaborative, and people-oriented companies will fare better with leadership that shares those same attributes.
What will it take to compete in the post-COVID-19 economy? A relentless focus on the outcomes that matter, new ways of working, and savvy use of digital and technology.
With millions of office employees suddenly working from home, companies are more exposed to cyber attack than ever before. Take these seven steps now to protect your IT and sensitive data.
New technologies are transforming the pharmaceutical industry’s approach to R&D. What’s happening now in the field—and what’s coming next?
Commercial applications are poised to go mainstream. Pharma and medtech companies, payers, and providers need to engage with the technology now.
The cyberrisks to the health care industry include more than ransomware and threaten more than hospitals. All kinds of companies and institutions are vulnerable.
To successfully navigate a digital transformation—and fend off digital attackers—companies must focus on three objectives: gaining speed, scaling rapidly, and delivering superior value.
Biopharma companies that make the most of big data combine strategic foresight, adaptive experimentation, and excellent execution.
